Anis Feki Interview: Key Insights from ESHRE 2026 on Reproductive Health
- Anis Feki shared updates on reproductive health research at ESHRE 2026.
- The interview focused on innovations in fertility treatments and patient care.
- Feki highlighted the need for personalized approaches in reproductive medicine.
- The discussion covered ethical considerations in assisted reproduction.
- Feki called for more global collaboration to address infertility challenges.
Expert Insights from ESHRE 2026
At the European Society of Human Reproduction and Embryology (ESHRE) 2026 annual meeting, EMJ sat down with Anis Feki, a prominent figure in reproductive medicine. The interview shed light on the latest developments shaping the field.
Feki, known for his work in fertility and reproductive health, spoke candidly about the current state of research. He stressed that the pace of innovation has accelerated, but challenges remain.
Advances in Fertility Treatments
One key topic was the progress in assisted reproductive technologies (ART). Feki pointed to improvements in embryo selection and genetic screening as game-changers. These tools, he said, are making treatments more effective and reducing risks for patients.
He also highlighted the growing role of artificial intelligence in the lab. AI models now help embryologists assess embryo quality with greater precision. This, Feki noted, could lead to higher success rates for couples undergoing IVF.
Personalised Medicine Takes Centre Stage
Feki emphasised that a one-size-fits-all approach no longer works in reproductive care. He argued for treatments tailored to individual genetic and hormonal profiles. This shift, he explained, requires better diagnostic tools and closer collaboration between clinicians and researchers.
The expert also addressed the rising issue of age-related infertility. He called for more public education on fertility preservation, especially for women. Egg freezing and other options, he said, should be discussed earlier in life.
Ethics and Access
Another major theme was ethics. Feki acknowledged the sensitive nature of embryo research and gene editing. He urged the medical community to proceed with caution, ensuring that regulations keep pace with science.
Access to treatment remains a global concern. Feki noted that infertility affects millions, yet many lack affordable care. He called for policy changes to make ART accessible to lower-income populations.
What Lies Ahead
The interview concluded with a look to the future. Feki predicted that the next decade will bring breakthroughs in uterine transplantation and stem cell therapies. He also stressed the importance of international data sharing to speed up discoveries.
As ESHRE 2026 continues, experts like Feki are pushing for a more inclusive, science-driven approach to reproductive health. The field is evolving fast, and the focus remains on helping patients build families safely.